UQ researchers launch the world's biggest drug survey

Researchers from The University of Queensland have launched the world's biggest drug survey, to gain insight into drug use around the globe.

The Global Drug Survey was founded by Professor Adam Winstock from University College London and has been running annually since 2012.

This year the survey is led by Dr Cheneal Puljevic from UQ's School of Public Health.

The aim of the Global Drug Survey is to make drug use safer for people, regardless of the drug's legality.

We hope to gain insight into drug use across the world, so we can inform individuals and organizations about what's going on in their communities and how best to reduce harms from drug use."

Dr Cheneal Puljevic from UQ's School of Public Health

This year respondents will be asked about drug prices, decriminalization, tobacco endgame policies, performance and image-enhancing drugs, nitrous oxide use and drug use in nightlife and festival settings.

It will also be the first Global Drug Survey to ask questions about the use of illicit tobacco.

Dr Puljevic said there had been very little international research into the tobacco black market.

"Illegal tobacco use has exploded in the past year, with some tobacconists in Australia selling packets of cigarettes for as little as $5," she said.

"But we don't really know much about who's using illicit tobacco or where they're getting it from."

The 2024 survey also includes questions about how peoples' drug use would change if drugs like MDMA and cocaine were decriminalized.

The anonymous online survey has been translated into 9 different languages and will be circulated worldwide.

It takes between 20 to 30 minutes to complete.

"The Global Drug Survey usually gets more than 100,000 respondents from more than 25 countries, so our goal is to exceed that this year," Dr Puljevic said.

"We want as many diverse perspectives as possible, with respondents of all ages, genders and sexual orientations and from rural and urban areas."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials